Gélisse Philippe, Crespel Arielle
Epilepsy Unit, Hôpital Gui de Chauliac, Montpellier, France.
Research Unit, Unité de Recherche sur les Comportements et Mouvements Anormaux, Institut national de la santé et de la recherche médicale (INSERM), Montpellier, France.
Epilepsia. 2025 Apr;66(4):1006-1013. doi: 10.1111/epi.18259. Epub 2025 Jan 4.
Contemporary studies report nonconvulsive status epilepticus (NCSE) in Creutzfeldt-Jakob disease (CJD), based on benzodiazepine (BZP)-responsive epileptiform discharges on the electroencephalogram (EEG), with the following false syllogism: (1) intravenous (IV) administration of BZPs usually suppress ictal activity in NCSE; (2) in CJD, periodic sharp wave complexes (PSWCs) are suppressed by IV BZPs; (3) therefore, these patients have NCSE. This is a simplistic and invalid conclusion, because authors of 20th-century science reports have clearly shown that IV BZPs, short-acting barbiturates, and drugs with no antiseizure effects, such as chloral hydrate and IV naloxone, suppress PSWCs, but patients fall asleep with no clinical improvement. In contrast, IV methylphenidate transiently improves both the EEG and clinical states. Unlike NCSE, which is unlikely to be stopped by external stimuli, PSWCs can be transiently stopped by sensory or painful stimulation. Since the end of the 1970s, the effect of spontaneous sleep on the disappearance of PSWCs has been well documented, with a description of a cycling alternating pattern. Phase A features periodic discharges and is associated with increased arousal, whereas phase B exhibits a reduction or suppression of the PSWCs and is associated with a reduction in the arousal level and hypotonia (non-rapid eye movement sleep). When considering the use of IV BZP administration during EEG as a diagnostic test, the sequence of disappearance of PSWCs at sleep onset and reappearance after each stimulation or sleep apnea episode is compelling evidence against NCSE, as is the observation of a pattern of stimulus-induced wakefulness with transient improvement of the EEG. The cycling alternating pattern during sleep and reactivity to sensory or painful stimulation disappear with increasing disease severity; however, this occurs in the later stages of the disease, where there is no diagnostic doubt.
当代研究报告了克雅氏病(CJD)中的非惊厥性癫痫持续状态(NCSE),其依据是脑电图(EEG)上苯二氮䓬(BZP)反应性癫痫样放电,并存在以下错误推理:(1)静脉注射(IV)BZPs通常可抑制NCSE中的发作活动;(2)在CJD中,静脉注射BZPs可抑制周期性锐波复合波(PSWCs);(3)因此,这些患者患有NCSE。这是一个简单化且无效的结论,因为20世纪科学报告的作者已明确表明,静脉注射BZPs、短效巴比妥类药物以及无抗癫痫作用的药物,如水合氯醛和静脉注射纳洛酮,均可抑制PSWCs,但患者会入睡且临床症状无改善。相比之下,静脉注射哌甲酯可短暂改善EEG和临床状态。与不太可能被外部刺激终止的NCSE不同,PSWCs可被感觉或疼痛刺激短暂终止。自20世纪70年代末以来,自发睡眠对PSWCs消失的影响已有充分记录,并描述了一种周期性交替模式。A期以周期性放电为特征,与觉醒增加相关,而B期表现为PSWCs减少或抑制,与觉醒水平降低和肌张力减退(非快速眼动睡眠)相关。当将EEG检查期间静脉注射BZP作为诊断测试时,睡眠开始时PSWCs消失以及每次刺激或睡眠呼吸暂停发作后重新出现的顺序是反对NCSE的有力证据,刺激诱发觉醒伴EEG短暂改善的观察结果也是如此。睡眠期间的周期性交替模式以及对感觉或疼痛刺激的反应性会随着疾病严重程度的增加而消失;然而,这发生在疾病后期,此时不存在诊断疑问。